Previous investigations on erythrocyte preservation (1-4) have demonstrated a marked effect of purine nucleosides on the metabolism of the red cell throughout storage. Attention has been focused upon the effect of adenosine in the maintenance of glucose metabolism and of high energy phosphate compounds, such as adenosine triphosphate (ATP). As a result, not only are the physical and chemical characteristics of the erythrocyte preserved, but the storage period, during which satisfactory post-transfusion viability is maintained, is extended to approximately twice that observed in acid-citrate-dextrose (ACD) preservative alone. It was postulated that the effect of adenosine was the result of an initial enzymatic conversion to inosine by a deaminase and the subsequent splitting of inosine to yield hypoxanthine and ribose-l-phosphate, mediated by a nucleoside phosphorylase (4, 5). Thus, it appeared that inosine might be the actual substrate for the initial enzymic reaction, and hence the preferred substance for viability studies. In order to evaluate a new preservative, it is desirable to correlate 1) the chemical characteristics of the stored red cells, 2) the ability of the cells to survive after transfusion, and 3) possible toxic effects of the preservative. Studies employing acid-citrate-dextroseinosine (ACDI) as a blood preservative are presented in this paper, as well as further investigations on the mechanism of action of purine nucleosides.
Previous investigations on erythrocyte preservation (1) (2) (3) (4) have demonstrated a marked effect of purine nucleosides on the metabolism of the red cell throughout storage. Attention has been focused upon the effect of adenosine in the maintenance of glucose metabolism and of high energy phosphate compounds, such as adenosine triphosphate (ATP). As a result, not only are the physical and chemical characteristics of the erythrocyte preserved, but the storage period, during which satisfactory post-transfusion viability is maintained, is extended to approximately twice that observed in acid-citrate-dextrose (ACD) preservative alone. It was postulated that the effect of adenosine was the result of an initial enzymatic conversion to inosine by a deaminase and the subsequent splitting of inosine to yield hypoxanthine and ribose-l-phosphate, mediated by a nucleoside phosphorylase (4, 5) . Thus , it appeared that inosine might be the actual substrate for the initial enzymic reaction, and hence the preferred substance for viability studies. In order to evaluate a new preservative, it is desirable to correlate 1) the chemical characteristics of the stored red cells, 2) the ability of the cells to survive after transfusion, and 3) possible toxic effects of the preservative. Studies employing acid-citrate-dextroseinosine (ACDI) as a blood preservative are presented in this paper, as well as further investigations on the mechanism of action of purine nucleosides.
METHODS
Procedures for the determination of phosphate partition, glucose, and osmotic fragility of erythrocytes have been described elsewhere (3, 6) .
Inosine, adenosine, deoxyadenosine, and adenine were obtained from Schwarz Laboratories; guanine, xanthine, 1This work was supported by research grants from the United States Atomic Energy Commission and the Office of the Surgeon General, Department of the Army.
hypoxanthine, guanosine, xanthosine, and ribose-5-phosphate from Nutritional Biochemicals Corporation. Adenosine mono-and tri-sulfate were gifts from Dr. A. Hock, and 2,6-diaminopurine riboside from Dr. G. B. Brown.
One-dimensional, paper chromatography on Whatman No. 1 filter paper was performed with several solvent systems; the Rf values for known standards are given in Table I . Identification of the purine compounds was accomplished by inspection of the papers under ultra violet light (Mineralite). After location of the spots, the materials could be eluted from the paper and measured spectrophotometrically.
The concentration of inosine in stock solutions was calculated from light absorption measurements at 247 muA in the Beckman DU spectrophotometer, using a millimolar extinction coefficient of 13.2 at pH 7.0. This value was determined on a weighed sample of pure inosine. Similarly, hypoxanthine concentration was determined at 249 mis using a millimolar extinction coefficient of 10.5 at pH 7.0. For a determination of total inosine concentration in plasma of blood treated with inosine, the light absorption of the sample was measured at 247 mxu using the untreated plasma as the control. In later experiments, it was found that hypoxanthine was present in the plasma of blood stored with inosine (or adenosine).
Since the molar extinction coefficients of hypoxanthine and inosine are different, the relative amounts of each could not be estimated directly from light absorption measure-ments alone. In this instance, the hypoxanthine was estimated enzymatically using xanthine oxidase (7) on a neutralized perchloric acid filtrate of the plasma, and this value used in conjunction with light absorption data to calculate the inosine concentration. Ammonia was measured with Nessler's reagent and adapted for use in the Beckman DU spectrophotometer (8) .
Post-transfusion survival of blood stored in ACDI was determined by the differential agglutination technique (Ashby) (9) with slight modifications, and by a double isotope method employing Cr' and P' (10) . The blood was collected from Type O-RH negative donors directly into plastic bags (kindly supplied by Cutter Laboratories) containing 75 ml. of ACD.2 Saline solutions of inosine were sterilized by filtration through an ultrafine fritted pyrex disc. The inosine was added immediately, and the blood was refrigerated at 4°C.
On the day of transfusion, the total blood volume of the recipient was determined with the use of PU tagged fresh cells. Smears of the stored blood were stained and examined as a precaution against bacterial contamination. The red cell count of the stored blood was enumerated, and the blood was weighed in order to determine the volume of blood to be infused. The stored blood was then infused over a 30-minute period, and an initial sample for counting of unagglutinable cells was obtained 10 minutes later. A previously prepared sample of Cr1 tagged stored cells was then injected, and samples for radioactive counting were obtained after 10, 20, and 30 minutes and at intervals throughout 10 days subsequently. Post-transfusion survival was calculated from the above data obtained with P" and Cr' measurements.
Samples for counting by the differential agglutination technique were obtained at intervals for 60 days following transfusion. The theoretical post transfusion unagglutinable count was calculated as follows: RBC/ml. X gmi blood injected Theoretical count =1.08 total blood volume (ml.)
Baseline unagglutinable counts were less than 2.5 X 10' cells per mm.' using powdered Anti-A serum. 8 The per cent survival, by both isotope and Ashby techniques at any given time, was determined from the ratio of the actual count to the theoretical count. These data were expressed graphically, and a straight line extrapolation was made to zero time. The value so obtained was designated "post-transfusion survival" and represents the percentage of cells which was viable after storage.
The hypotensive effect of solutions of inosine and hypoxanthine, when administered intravenously, was measured by recording directly the arterial pressure in dogs as described previously (3). In addition, 250 ml. of plasma from blood stored in ACDI was infused intravenously into a volunteer recipient. The blood pressure, 2National Institutes of Health, Formula B.
s We are indebted to Lederle Laboratories for the antiserum used in these studies.
pulse, and respiratory rate were recorded at one-minute intervals during the infusion, and for one hour subsequently. Similar recordings were made for each recipient of blood stored in ACDI.
RESULTS

A. Reversal of the storage lesion with inosine
The relative order of activity of purine nucleosides in the regeneration of phosphorylated esters of the stored erythrocyte was studied with human blood which had been stored 25 days. The blood was divided into 5 aliquots, and 1,300 ,umoles of nucleoside were added per 100 ml. of red cells. The compounds tested were adenosine, inosine, xanthosine, and guanosine; one aliquot without nucleosides served as a control. All samples were incubated at 370 for 45 min., and erythrocyte phosphate partitions were determined subsequently. From a series of experiments, a representative of which is shown in Table TI , it was found that inosine was the most effective agent in promoting resynthesis of phosphate esters. In hemolysate systems the same relative order of activity of the nucleosides has been demonstrated (5). Deoxyadenosine and 2,6-diaminopurine riboside were somewhat less effective than xanthosine in the intact cell system, while adenosine mono-and trisulfate were inactive. The purine bases, adenine, hypoxanthine, guanine, and xanthine, and ribose, alone, or in combination, were all likewise inactive, although ribose-5-phosphate was shown to have comparable activity to inosine in the hemolysate system. The inability of ribose-5-phosphate (and other phosphate esters) to penetrate adequately the intact cell made it impossible to assess its effectiveness in this system.
The utilization of adenosine can be attributed to its initial conversion to inosine, according to equation (1), adenosine + H20 -* inosine + NH3 (1) since ammonia was found to be released in equimolar amounts when adenosine was incubated with stored erythrocytes (cf. Table III) .4 This enzymatic conversion is rapid, since, after one hour incubation of adenosine with erythrocytes, inosine and hypoxanthine are the only substances present, in other tissues. Prankerd (14) has suggested that adenosine is cleaved directly to adenine by intact erythrocytes, but his identification of the purine was based upon paper chromatography in a single solvent system, viz. n-butanol: formic acid:water (77:10:13), and it was not stated whether hypoxanthine and adenine were separable under these conditions,6 or even whether hypoxanthine was considered as a possible product.
Paper chromatographic evidence indicated that the purine reaction product of the utilization of inosine or adenosine during storage is hypoxanthine, and that of guanosine is guanine. The pathway of the utilization of xanthosine is being investigated, and an initial conversion to guanosine seems likely.
TABLE III
Release of ammonia from adenosine Twelve-ml. aliquots of human blood stored 32 days were incubated 1 hour at 370 with adenosine, inosine, or 2,6-diaminopurine riboside. The control sample contained saline. The total volume in each case was 14 ml., but the results were calculated for 100 ml. of whole blood. 
B. Studies on erythrocytes stored in ACDI
Inasmuch as inosine appeared to be the nucleoside of choice for reversal of the storage lesion, chemical and post-transfusion survival studies were carried out on blood stored in ACDI. Three units of Type O-RH negative blood were drawn into plastic bags containing ACD. Approximately 3400 jumoles inosine per 100 ml. red cells were added to each. The blood was stored at 40 for 42 days (Unit 1), 43 days (Unit 2), and 46 days (Unit 3). At these times, chemical analyses and post-transfusion survival measurements were performed.
Chemical studies
Illustrative data are shown in Table IV , which indicate that certain physical and chemical characteristics of these red cells were maintained well There is a considerable quantity of hypoxanthine (measured enzymatically with xanthine oxidase) in the plasma of blood after storage in ACDI. This is assumed to be the result of the uptake of inosine and its metabolism by the cell 7 with subsequent outward diffusion of hypoxanthine 7 Since erythrocytes or plasma are not thought to contain xanthine oxidase, it is not unexpected that hypoxanthine should accumulate under these conditions. umoles of inosine and 3,000 jumoles of hypoxanthine in the plasma. The remaining 2,400 ,umoles (obtained by subtraction of 1,500 plus 3,000, or 4,500, from 6,900 Jumoles) would represent the actual "intracellular" amount and could be in the form of either inosine or hypoxanthine. From the finding that 1,500 of the initial 6,900 ,umoles of inosine remained in the plasma, the percentage "absorption" of inosine was therefore (6,900-1,500)/6,900, or 78 per cent. These amounts are only order-of-magnitude approximations, and further analytical details will be reported in a subsequent communication. It is important to recognize, however, that the amount of purine base, hypoxanthine, in the plasma increases during storage as a reflection of the metabolic breakdown of inosine. In another experiment it was shown that even after a short period of storage in ACDI, i.e.,
Survival studies
The survival data of erythrocytes stored in ACDI are plotted in Figure 1 . Each curve represents the transfusion of one of the three units of stored blood described previously in this paper. The average post-transfusion survival of these cells, stored about 6 to 7 weeks, was 82 per cent.
Comparable survival values were obtained with the use of Cr51 tagging, as shown in Table V . Following the initial phase of rapid destruction of non-viable cells, the destruction rate over the following two months approximated 1 per cent per day and was comparable to that obtained when fresh cells were transfused.
C. Toxicity studies wvith inosine
In order to determine the systemic effect of the intravenous administration of the inosine component of the ACDI preservative, studies were carried out in the dog, human, and rabbit. It was demonstrated previously that the intravenous administration of 1 jumole of adenosine per Kg. in the dog and rabbit produced a fall in arterial pressure of approximately 80 mm. Hg with a return to normal in 4 to 10 seconds (3). In contrast, 70 to 80 ,Fmoles of inosine per Kg. were required to produce the same hypotensive effect observed with only 1 Mumole of adenosine. The purity of the inosine sample used in these experiments was estimated by paper chromatographic analysis, considered sensitive enough to detect contamination by adenosine of 1 to 2 per cent, and by assay with adenosine deaminase, sensitive to 0.5 per cent. Both assays gave negative results. Despite these results it cannot be said with certainty that the hypotensive effect was specifically related to inosine rather than to a trace of adenosine ( < 0.5 per ml. of red cells) was injected into a human recipient at rates up to 15 to 20 ml. per minute without effect on the respiration, pulse, or blood pressure. There were, likewise, no reactions in the recipients during the infusion of the 3 units of whole blood stored in ACDI.
DISCUSSION
There is a characteristic pattern of chemical and morphological deterioration of stored erythrocytes which is associated with a decrease in posttransfusion viability. It has been shown previously that these changes are not the result of an acceleration of normal in vivo senescence of the red cell (6) , and that they are unaffected by variations in the extra-erythrocytic environment during storage (16) . With the use of an exchange transfusion technique, it was shown that these effects of storage are reversible in vivo and that cells surviving the immediate post-transfusion period are capable of withstanding another interval of storage (17) . These observations demonstrated that the limiting factor is an intrinsic metabolic failure of the cells which leads to loss of cell viability.
Further studies indicated that the red cell can utilize purine nucleosides, especially adenosine, in two ways (1-3): 1 ) To reverse the storage lesion in vitro, and 2) To retard the onset of the storage lesion with a resultant prolongation of the effective period of storage.
In the present study the relative order of effectiveness of these nucleosides in the reversal of the storage lesion, as indicated by a resynthesis of organic phosphate esters, was found to be: inosine > adenosine > guanosine > xanthosine. This could be demonstrated in both hemolysate and intact cell systems. The above evidence, and the fact that red cell rejuvenation involves the reincorporation of inorganic phosphate into the organic phosphate fraction, suggested that a purine * Results with the Cr61 method average 5 to 10 per cent lower than those obtained with the Ashby technique due to the excessive loss of Cr51 during the first 24 hours (10) . nucleoside phosphorylase mediated the primary reaction. In a separate study this enzyme has been isolated from human erythrocytes in highly purified form (5) . In hemolysate systems, the nucleosides were shown to exhibit the same relative order of activity for enzymatic phosphorolysis as in the rejuvenation phenomenon. Studies with the purified enzyme, however, indicated that only inosine and guanosine were the actual substrates for the enzymatic reaction, and thus implied that adenosine and xanthosine must be converted to either inosine or guanosine prior to phosphorolysis (5) . It is, of course, possible that adenosine or xanthosine phosphorylases may exist in the cell or hemolysate and may be lost subsequently upon isolation. However, it should be noted that phosphorylases for these substrates have not been found elsewhere, and that other purine nucleoside phosphorylases split only inosine and guanosine.
It has been shown previously (5) and in the present communication that adenosine undergoes a rapid conversion to inosine with the concomitant production of ammonia and that there is a subsequent cleavage of inosine which yields hypoxanthine as one of the reaction products. Consequently, inosine appears to be the actual effective agent in blood preservation, and the use of adenosine not only introduces an unnecessary side product, ammonia, but may be unsafe for transfusion of whole units of blood due to its marked hypotensive properties when present even in trace amounts. Hypoxanthine had no depressor effect, and that of the inosine preparations used was in the order of magnitude of about 1/100 that of adenosine. Previously, it has been reported (18) that inosine is 1/20 as hypotensive as adenosine. This higher value may be in error owing to the possibility that the inosine, available at that time, may have been contaminated with adenosine.
Blood stored in ACDI contains increasing amounts of hypoxanthine in the plasma as the time of storage progresses, and further studies of the fate of hypoxanthine and its metabolic products in the body, i.e., xanthine and uric acid, are desirable before multiple transfusions of blood stored in ACDI can be advocated.
A study of the viability of erythrocytes stored in ACDI indicated, with both Ashby and Cr5l techniques (when allowance is made for excessive Cr51 loss during the first 24 hours after transfusion), an average post-transfusion survival of about 82 per cent at 6 weeks of storage. After the immediate destruction of non-viable cells, subsequent loss of transfused cells occurred at a normal rate (approximately 1 per cent per day). Comparable studies on blood stored in ACD alone revealed approximately 10 per cent survival 1 to 2 days after transfusion (10) . In the present investigation, a concentration of about 3,400 ,umoles inosine per 100 ml. of red cells was employed at the beginning of storage. The optimal level of this nucleoside for preservation has not been determined as yet, and it is possible that the storage period of satisfactory viability may be extended even further than the 6 weeks indicated by the present data.
SUMMARY
The relative order of activity of purine nucleosides in the regeneration of phosphorylated esters of the stored erythrocyte has been established as follows: inosine > adenosine > guanosine > xanthosine. The utilization of adenosine by the red cell involves an initial conversion to inosine, and the subsequent purine metabolite is hypoxanthine. The plasma of blood stored in ACDI contains increasing amounts of hypoxanthine during storage.
The intravenous administration of inosine or hypoxanthine has only a questionable hypotensive effect in comparison with the pronounced hypotensive properties of adenosine.
The post-transfusion survival of cells stored in ACDI for 6 to 7 weeks is about 82 per cent as indicated by the differential agglutination and Cr51 techniques.
